Literature DB >> 269763

The clinical features of chronic granulocytic leukaemia.

A S Spiers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 269763

Source DB:  PubMed          Journal:  Clin Haematol        ISSN： 0308-2261


× No keyword cloud information.
  8 in total

1.  Inducible activation of CEBPB, a gene negatively regulated by BCR/ABL, inhibits proliferation and promotes differentiation of BCR/ABL-expressing cells.

Authors:  Clara Guerzoni; Michela Bardini; Samanta A Mariani; Giovanna Ferrari-Amorotti; Paolo Neviani; Maria Luisa Panno; Ying Zhang; Robert Martinez; Danilo Perrotti; Bruno Calabretta
Journal:  Blood       Date:  2006-01-17       Impact factor: 22.113

Review 2.  Genetic events other than BCR-ABL1.

Authors:  Paolo Neviani
Journal:  Curr Hematol Malig Rep       Date:  2014-03       Impact factor: 3.952

3.  Chronic myeloid leukemia associated with impairment of hearing.

Authors:  C K Williams; O Ogan
Journal:  Br Med J (Clin Res Ed)       Date:  1985-06-08

4.  Chronic leukaemia: an African experience.

Authors:  C C Okany; O O Akinyanju
Journal:  Med Oncol Tumor Pharmacother       Date:  1989

Review 5.  Basophils and allergic inflammation.

Authors:  Mark C Siracusa; Brian S Kim; Jonathan M Spergel; David Artis
Journal:  J Allergy Clin Immunol       Date:  2013-10       Impact factor: 10.793

6.  Oncogenic Signalling of Growth Factor Receptors in Cancer: Mechanisms and Therapeutic Opportunities.

Authors:  Anica Dricu
Journal:  Int J Mol Sci       Date:  2022-07-02       Impact factor: 6.208

7.  Polymorphism T81C in H-RAS Oncogene Is Associated With Disease Progression in Imatinib (TKI) Treated Chronic Myeloid Leukemia Patients.

Authors:  Rashid Mir; Imtiyaz Ah; Jamsheed Javid; Mariyam Zuberi; Sameer Guru; Masroor Mirza; Shazia Farooq; Prasant Yadav; Prakash C Ray; Naresh Gupta; Alpana Saxena
Journal:  World J Oncol       Date:  2015-04-12

8.  The Molecular Role of HIF1α Is Elucidated in Chronic Myeloid Leukemia.

Authors:  Vivek Singh; Ranjana Singh; Rashmi Kushwaha; Shailendra Prasad Verma; Anil Kumar Tripathi; Abbas Ali Mahdi
Journal:  Front Oncol       Date:  2022-06-30       Impact factor: 5.738
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.